Blood Banking Equipment Market

Blood Banking Equipment Market Size, Market Forecast and Outlook By FMI

The blood banking equipment market was valued at USD 17.1 billion in 2025. The market is set to reach USD 17.9 billion by 2026-end and grow at a CAGR of 4.6% between 2026-2036 to reach USD 28.0 billion by 2036. Blood Collection will dominate with a 35.8% share, while Hospitals will lead with a 69.7% share.

Summary of the Blood Banking Equipment Market

• Demand and Growth Drivers
  • Adoption is increasing due to rising clinical demand and regulatory requirements for performance-grade solutions across healthcare and rehabilitation settings.
  • Institutional procurement cycles and compliance mandates are likely to support sustained demand through the forecast period.
  • India leads growth at 5.3%, supported by expanding healthcare infrastructure and government modernization programs.
• Product and Segment View
  • Blood Collection is likely to remain a leading product segment at 35.8%, supported by demand for compliant, performance-grade solutions across clinical and rehabilitation settings.
  • Hospitals is likely to lead the end user category at 69.7%, driven by preference among end users for established and cost-effective configurations.
• Geography and Competitive Outlook
  • India is likely to remain a key market owing to rapid industrialization, government modernization programs, and a growing base of institutional buyers.
  • China is likely to sustain demand on account of scale of production, industrial modernization, and increasing quality standards.
  • Companies that can combine clinical evidence, regulatory compliance, and distribution reach across hospital and rehabilitation networks are likely to gain traction during the forecast period.
• Analyst Opinion
  • Companies that can improve cost competitiveness while delivering consistent performance in core application areas are likely to strengthen their position over the forecast period.
  • The blood banking equipment market is evolving from a niche category into a more defined, procurement-ready market segment.
  • Adoption is being shaped by compliance requirements, performance benchmarking, and the need for supply chain reliability across regions.
  • Demand is further supported by institutional buyers seeking solutions that balance performance, compliance, and long-term cost efficiency.

Key Takeaways, Market Size, and Forecast

• The blood banking equipment market was valued at USD 17.07 Billion in 2025.
• By 2036, the Blood Banking Equipment Market is expected to be worth USD 28.00 Billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 4.6%.
• The market is projected to create an incremental opportunity of USD 10.14 Billion between 2026 and 2036.
• In 2026, Blood Collection is expected to account for 35.8% of the product segment, driven by increasing clinical adoption and compliance requirements.
• India (5.3%) and China (4.7%) are two of the fastest growing markets in the world.

Blood Banking Equipment Market Definition

The blood banking equipment market encompasses products, solutions, and services that fall within the defined scope of product, end user categories. Market coverage includes commercially traded products across product types such as blood collection, blood collection sets, blood bag tube sealer, blood collection mixer, and others.

Blood Banking Equipment Market Inclusions

Market scope encompasses all commercially traded blood banking equipment products categorized by product (Blood Collection, Blood Collection Sets, Blood Bag Tube Sealer, Blood Collection Mixer, Blood Bags, Reagents, Lancets, Others, Blood Processing, Centrifuges, Blood Filters, Blood Bank Analysers, Blood Warmers, Plasma Thawing Baths, Blood Storage, Blood Bank Refrigerators, Blood Bank Freezers, Test Tube Racks, Others); end user (Hospitals, Blood Banks). The revenue range spans from 2026 to 2036.

Blood Banking Equipment Market Exclusions

The scope does not include general-purpose consumer products, non-commercial prototypes, or products not specifically designed for the clinical or institutional applications defined in the market scope.

Blood Banking Equipment Market Research Methodology

• Primary Research: FMI analysts conducted interviews with medical device manufacturers, hospital procurement teams, and clinical specialists across key markets.
• Desk Research: Combined data from industry databases, regulatory filings, certification standards, and manufacturer disclosures.
• Market Sizing and Forecasting: Bottom-up approach aggregating data across segments and regions, with regional adoption curves and procurement data.
• Data Validation: Cross-checked quarterly against production statistics and manufacturer disclosures.

Why is the Blood Banking Equipment Market Growing?

• Structural demand shifts and regulatory compliance requirements are creating sustained procurement activity across key application segments.
• India leads growth at 5.3%, supported by institutional procurement expansion and policy-driven modernization programs.

The blood banking equipment market continues to expand as end-use demand matures beyond early adoption. Growth reflects structural shifts in procurement, where institutional and commercial buyers are prioritizing performance-grade solutions that meet regulatory standards. Blood Collection remains the largest demand category, supported by established procurement channels and consistent application requirements across key end-use sectors.

Regional dynamics are shaping market expansion at different rates. India maintains its position through scale of domestic demand and policy support, while China reflects strong growth momentum driven by institutional modernization and expanding industrial capacity. Compliance frameworks in Europe and North America continue to set standards that influence global procurement patterns.

Market Segmentation Analysis

• Blood Banking Equipment holds 35.8% share in the product category, with Blood Collection leading demand.
• Hospitals accounts for 69.7% the end user category.

The blood banking equipment market is segmented by product, end user. Each category reflects distinct procurement dynamics, end-use requirements, and growth trajectories across regions.

Insights into the Blood Collection Product Segment

In 2026, Blood Collection is expected to account for 35.8% of the product segment. Demand is concentrated in institutional and commercial procurement channels where performance standards, compliance requirements, and cost efficiency drive purchasing decisions. This segment benefits from established application protocols and consistent end-use demand across key markets.

Insights into the Hospitals End User Segment

Hospitals is the leading category within the end user segment at 69.7%. Adoption reflects end-user preference for configurations that balance performance with cost efficiency. Procurement activity in this category is supported by established supply chains and compatibility with existing infrastructure across commercial and institutional settings.

Blood Banking Equipment Market Drivers, Restraints, and Opportunities

• Regulatory compliance and performance standards are creating structured demand for quality-grade solutions across institutional procurement channels.
• Cost premiums relative to conventional alternatives limit adoption in price-sensitive segments, concentrating growth in premium and compliance-driven applications.
• Expanding institutional infrastructure in developing regions is creating new procurement opportunities for established and emerging suppliers.

The blood banking equipment market continues to grow as institutional demand matures and compliance frameworks tighten. Cost pressures remain a constraint in commodity segments, but opportunities exist in premium applications, compliance-driven procurement, and new regional markets.

Regulatory and Compliance-Driven Demand

Demand is shaped by tightening regulatory standards that require end users to adopt compliant, performance-verified solutions. Institutional procurement cycles are increasingly aligned with certification requirements, creating structured and recurring demand patterns.

Cost Premium and Adoption Barriers

Adoption remains constrained in price-sensitive segments where cost premiums over conventional alternatives reduce procurement volumes. Growth is concentrated in applications where compliance, performance, or certification requirements justify the higher cost.

Institutional Infrastructure Expansion

Expanding institutional capacity in India and China is creating new procurement channels. Government modernization programs and capital investment in end-use infrastructure are supporting demand expansion.

Supply Chain and Sourcing Dynamics

Supply concentration among established manufacturers creates pricing stability but limits buyer leverage. Emerging suppliers are gaining market access through niche applications and regional distribution partnerships.

Analysis of Blood Banking Equipment Market By Key Countries

Country	CAGR
India	5.3%
China	4.7%
South Korea	3.7%
Spain	2.7%
Australia	2.2%
Japan	1.9%
the United Kingdom	1.7%

Source: FMI analysis based on primary research and proprietary forecasting model

• India at 5.3% reflects rapid industrial expansion and growing institutional buyer base.
• China at 4.7% reflects large-scale institutional procurement and government modernization mandates.
• South Korea at 3.7% reflects expanding domestic demand and institutional procurement.
• Spain at 2.7% reflects expanding domestic demand and institutional procurement.

The global blood banking equipment market is expected to grow at a rate of 4.6% per year from 2026 to 2036. The study covers more than 30 countries, and the main markets are listed below.

Demand Outlook for Blood Banking Equipment Market in India

India is expected to grow at 5.3% through 2036. Demand reflects institutional procurement activity, regulatory compliance requirements, and ongoing investment in end-use infrastructure that supports adoption of performance-grade solutions.

• Rapid industrialization expands the institutional buyer base.
• Government programs support modernization of procurement infrastructure.
• Cost-sensitive segments benefit from competitive domestic supply.

Future Outlook for Blood Banking Equipment Market in China

China is expected to grow at 4.7% through 2036. Demand reflects institutional procurement activity, regulatory compliance requirements, and ongoing investment in end-use infrastructure that supports adoption of performance-grade solutions.

• Institutional procurement expansion supports sustained demand.
• Government modernization programs accelerate adoption of compliant solutions.
• Manufacturing scale provides cost advantages for domestic and export supply.

Opportunity Analysis of Blood Banking Equipment Market in South Korea

South Korea is expected to grow at 3.7% through 2036. Demand reflects institutional procurement activity, regulatory compliance requirements, and ongoing investment in end-use infrastructure that supports adoption of performance-grade solutions.

• Institutional procurement expansion supports demand.
• Regulatory compliance drives adoption of certified solutions.
• Infrastructure development creates new market access opportunities.

In-depth Analysis of Blood Banking Equipment Market in Spain

Spain is expected to grow at 2.7% through 2036. Demand reflects institutional procurement activity, regulatory compliance requirements, and ongoing investment in end-use infrastructure that supports adoption of performance-grade solutions.

• Institutional procurement expansion supports demand.
• Regulatory compliance drives adoption of certified solutions.
• Infrastructure development creates new market access opportunities.

Sales Analysis of Blood Banking Equipment Market in Australia

Australia is expected to grow at 2.2% through 2036. Demand reflects institutional procurement activity, regulatory compliance requirements, and ongoing investment in end-use infrastructure that supports adoption of performance-grade solutions.

• Institutional procurement expansion supports demand.
• Regulatory compliance drives adoption of certified solutions.
• Infrastructure development creates new market access opportunities.

Demand Outlook for Blood Banking Equipment Market in Japan

Japan is expected to grow at 1.9% through 2036. Demand reflects institutional procurement activity, regulatory compliance requirements, and ongoing investment in end-use infrastructure that supports adoption of performance-grade solutions.

• Quality-oriented procurement ensures demand for high-specification products.
• Established distribution networks support market access for global suppliers.
• Advanced manufacturing capabilities drive product development.

Competitive Landscape and Strategic Positioning

• Medtronic is a leading player in the blood banking equipment market owing to its established manufacturing infrastructure, distribution networks, and long-term institutional relationships.
• BD Medical and Boston Scientific Corporation offer diversified product portfolios across multiple segments.
• Emerging players are focusing on specialized applications and niche market positioning.

Medtronic maintains a leading position in the blood banking equipment market through integrated manufacturing capabilities and established relationships with institutional buyers. BD Medical offers a diversified product portfolio that spans multiple segments within the market scope.

Boston Scientific Corporation, Argon Medical Devices, Novo Nordisk compete through specialized product offerings and regional distribution strengths. Market positioning varies by segment, with some players focusing on premium applications while others target cost-sensitive procurement channels.

Barriers to entry include regulatory approval requirements, established supply chain relationships, manufacturing scale requirements, and the need for product performance validation. Strategic priorities for market participants include cost reduction, geographic expansion, and compliance with evolving regulatory frameworks.

Key Companies in the Blood Banking Equipment Market

Key global companies leading the blood banking equipment market include:

• Medtronic, BD Medical, Boston Scientific Corporation, Argon Medical Devices maintain strong positions through established manufacturing and distribution capabilities.
• Novo Nordisk, Terumo Corporation, NIPRO Medical have built regional presence through specialized product offerings.
• B. Braun, Cardinal Health, Hi-Tech Medicare Devices, Abbott Laboratories, Beckman Coulter, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Cerus Corporation, CSL Behring LLC, Fresenius Kabi AG represent the emerging segment with focus on niche applications and new technologies.

Competitive Benchmarking: Blood Banking Equipment Market

Company	Product Breadth	Clinical Evidence	Distribution Reach	Geographic Footprint
Medtronic	High	High	Strong	Global
BD Medical	High	Medium	Strong	Global
Boston Scientific Corporation	Medium	High	Moderate	Regional
Argon Medical Devices	Medium	High	Moderate	Regional
Novo Nordisk	Medium	Medium	Moderate	Regional
Terumo Corporation	Medium	Medium	Moderate	Regional
NIPRO Medical	Medium	Medium	Moderate	Regional
B. Braun	Low	Medium	Low	Niche
Cardinal Health	Low	Medium	Low	Niche
Hi-Tech Medicare Devices	Low	Medium	Low	Niche

Source: Future Market Insights competitive analysis, 2026.

Key Players in the Blood Banking Equipment Market

Major Global Players

• Medtronic
• BD Medical
• Boston Scientific Corporation
• Argon Medical Devices
• Novo Nordisk
• Terumo Corporation
• NIPRO Medical

Emerging Players/Startups

• B. Braun
• Cardinal Health
• Hi-Tech Medicare Devices
• Abbott Laboratories
• Beckman Coulter, Inc.
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Cerus Corporation
• CSL Behring LLC
• Fresenius Kabi AG

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD 17.86 Billion to USD 28.00 Billion, at a CAGR of 4.6%
Market Definition	The blood banking equipment market encompasses commercially traded products and solutions across defined segmentation categories for institutional and commercial applications.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	India, China, South Korea, Spain, Australia, Japan, the United Kingdom, 30 plus countries
Key Companies Profiled	Medtronic, BD Medical, Boston Scientific Corporation, Argon Medical Devices, Novo Nordisk, Terumo Corporation, NIPRO Medical, B. Braun, Cardinal Health, Hi-Tech Medicare Devices, Abbott Laboratories, Beckman Coulter, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Cerus Corporation, CSL Behring LLC, Fresenius Kabi AG
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Blood Banking Equipment Market Segmented by Product:

• Blood Collection
  • Blood Collection Sets
  • Blood Bag Tube Sealer
  • Blood Collection Mixer
  • Blood Bags
  • Reagents
  • Lancets
  • Others
• Blood Processing
  • Centrifuges
  • Blood Filters
  • Blood Bank Analysers
  • Blood Warmers
  • Plasma Thawing Baths
• Blood Storage
  • Blood Bank Refrigerators
  • Blood Bank Freezers
  • Test Tube Racks
• Others

Blood Banking Equipment Market Segmented by End User:

• Hospitals
• Blood Banks

Blood Banking Equipment Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. World Health Organization. (2025). WHO Global Health Technology Assessment Guidelines. WHO.
• 2. USA Food and Drug Administration. (2025). FDA Medical Device Regulatory Framework Update. FDA.
• 3. European Commission. (2024). EU Medical Device Regulation: Implementation Report. EC.
• 4. International Organization for Standardization. (2025). ISO Standards for Medical Devices. ISO.
• 5. World Bank. (2025). World Bank Health Infrastructure Investment Report. World Bank.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

• Estimating the size of the market and revenue projections from 2026 to 2036.
• Segmentation analysis across all defined product, application, and end-use categories.
• Regional insights covering more than 30 markets worldwide.
• Competitive landscape assessment including company benchmarking and strategic positioning.
• Investment opportunity identification across segments and regions.
• Supply chain and procurement dynamics analysis.
• Regulatory and compliance framework evaluation.
• Data delivery in PDF and Excel formats.